相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Multifaceted chemical behaviour of metallocene (M = Fe, Os) quinone methides. Their contribution to biology
Anne Vessieres et al.
COORDINATION CHEMISTRY REVIEWS (2021)
A Drug Screening Pipeline Using 2D and 3D Patient-Derived In Vitro Models for Pre-Clinical Analysis of Therapy Response in Glioblastoma
Sakthi Lenin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
ROS in cancer therapy: the bright side of the moon
Bruno Perillo et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Characterization of molecular pathways for targeting therapy in glioblastoma
Naveed Wagle et al.
CHINESE CLINICAL ONCOLOGY (2020)
Atypical Lone Pair-π Interaction with Quinone Methides in a Series of Imido-Ferrociphenol Anticancer Drug Candidates
Yong Wang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Glioblastoma heterogeneity and the tumour microenvironment: implications for preclinical research and development of new treatments
Sally L. Perrin et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2019)
Small Structural Differences between Two Ferrocenyl Diphenols Determine Large Discrepancies of Reactivity and Biological Effects
Federica Tonolo et al.
CHEMMEDCHEM (2019)
Pharmaco-genomic investigations of organo-iridium anticancer complexes reveal novel mechanism of action
Jessica M. Hearn et al.
METALLOMICS (2018)
A new generation of ferrociphenols leads to a great diversity of reactive metabolites, and exhibits remarkable antiproliferative properties
Yong Wang et al.
CHEMICAL SCIENCE (2018)
Multi-omics analysis of primary glioblastoma cell lines shows recapitulation of pivotal molecular features of parental tumors
Shai Rosenberg et al.
NEURO-ONCOLOGY (2017)
A New Series of Succinimido-ferrociphenols and Related Heterocyclic Species Induce Strong Antiproliferative Effects, Especially against Ovarian Cancer Cells Resistant to Cisplatin
Pascal Pigeon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment
Qianghu Wang et al.
CANCER CELL (2017)
Glioblastoma targeted therapy: updated approaches from recent biological insights
M. Touat et al.
ANNALS OF ONCOLOGY (2017)
Oxaliplatin in the era of personalized medicine: from mechanistic studies to clinical efficacy
Paola Perego et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Mitochondrial Thioredoxin System as a Modulator of Cyclophilin D Redox State
Alessandra Folda et al.
SCIENTIFIC REPORTS (2016)
Organometallic Antitumor Compounds: Ferrocifens as Precursors to Quinone Methides
Yong Wang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
STAT3 Blockade Inhibits Radiation-Induced Malignant Progression in Glioma
Jasmine Lau et al.
CANCER RESEARCH (2015)
Ferrocifen type anti cancer drugs
Gerard Jaouen et al.
CHEMICAL SOCIETY REVIEWS (2015)
Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter-still a dilemma?
Monika E. Hegi et al.
NEURO-ONCOLOGY (2015)
Potent organo-osmium compound shifts metabolism in epithelial ovarian cancer cells
Jessica M. Hearn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
Gain of Function of Mutant TP53 in Glioblastoma: Prognosis and Response to Temozolomide
Xiang Wang et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Quantitative Analyses of ROS and RNS Production in Breast Cancer Cell Lines Incubated with Ferrocifens
Cong Lu et al.
CHEMMEDCHEM (2014)
Evidence for Targeting Thioredoxin Reductases with Ferrocenyl Quinone Methides. A Possible Molecular Basis for the Antiproliferative Effect of Hydroxyferrocifens on Cancer Cells
Anna Citta et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
The in vivo performance of ferrocenyl tamoxifen lipid nanocapsules in xenografted triple negative breast cancer
Anne-Laure Laine et al.
BIOMATERIALS (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Mutant TP53 enhances the resistance of glioblastoma cells to temozolomide by up-regulating O6-methylguanine DNA-methyltransferase
Xiang Wang et al.
NEUROLOGICAL SCIENCES (2013)
Individualized Targeted Therapy for Glioblastoma Fact or Fiction?
Michael Weller et al.
CANCER JOURNAL (2012)
Deciphering the Activation Sequence of Ferrociphenol Anticancer Drug Candidates
Pierluca Messina et al.
CHEMISTRY-A EUROPEAN JOURNAL (2012)
Characterization of an Oxaliplatin Sensitivity Predictor in a Preclinical Murine Model of Colorectal Cancer
Mickey K. Kim et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Treatment of 9L Gliosarcoma in Rats by Ferrociphenol-Loaded Lipid Nanocapsules Based on a Passive Targeting Strategy via the EPR Effect
Ngoc Trinh Huynh et al.
PHARMACEUTICAL RESEARCH (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Synthesis, Cytotoxicity, and COMPARE Analysis of Ferrocene and [3]Ferrocenophane Tetrasubstituted Olefin Derivatives against Human Cancer Cells
Meral Goermen et al.
CHEMMEDCHEM (2010)
A ferrocenyl derivative of hydroxytamoxifen elicits an estrogen receptor-independent mechanism of action in breast cancer cell lines
Anne Vessieres et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2010)
Ferrocenyl Quinone Methides as Strong Antiproliferative Agents: Formation by Metabolic and Chemical Oxidation of Ferrocenyl Phenols
Didier Hamels et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Promoter Methylation and Polymorphisms of the MGMT Gene in Glioblastomas: A Population-Based Study
Izabela Zawlik et al.
NEUROEPIDEMIOLOGY (2009)
Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas
Emilie Allard et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Evaluation of cytotoxic properties of organometallic ferrocifens on melanocytes, primary and metastatic melanoma cell lines
Qq Michard et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2008)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Radiotherapy for glioblastoma in the elderly
Florence Keime-Guibert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The influence of phenolic hydroxy substitution on the electron transfer and anti-cancer properties of compounds based on the 2-ferrocenyl-1-phenyl-but-1-ene motif
Elizabeth Anne Hillard et al.
DALTON TRANSACTIONS (2007)
French brain tumor data bank: Methodology and first results on 10,000 cases
Luc Bauchet et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
S. Fulda et al.
ONCOGENE (2006)
Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines
Jeongwu Lee et al.
CANCER CELL (2006)
Ferrocene-mediated proton-coupled electron transfer in a series of ferrocifen-type breast-cancer drug candidates
E Hillard et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2006)
Modification of the estrogenic properties of diphenols by the incorporation of ferrocene.: Generation of antiproliferative effects in vitro
A Vessières et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Adult glioma incidence trends in the United States, 1977-2000
KR Hess et al.
CANCER (2004)
Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens:: Evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines
S Top et al.
CHEMISTRY-A EUROPEAN JOURNAL (2003)
Transferrin receptor-dependent iron uptake is responsible for doxorubicin-mediated apoptosis in endothelial cells - Role of oxidant-induced iron signaling in apoptosis
S Kotamraju et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Studies on organometallic selective estrogen receptor modulators.: (SERMs) Dual activity in the hydroxy-ferrocifen series
S Top et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2001)
On the mechanism of the antitumor activity of ferrocenium derivatives
D Osella et al.
INORGANICA CHIMICA ACTA (2000)
分享论文
